rs13321831

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003722.5(TP63):​c.325-21570G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0876 in 151,960 control chromosomes in the GnomAD database, including 652 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.088 ( 652 hom., cov: 32)

Consequence

TP63
NM_003722.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.605

Publications

4 publications found
Variant links:
Genes affected
TP63 (HGNC:15979): (tumor protein p63) This gene encodes a member of the p53 family of transcription factors. The functional domains of p53 family proteins include an N-terminal transactivation domain, a central DNA-binding domain and an oligomerization domain. Alternative splicing of this gene and the use of alternative promoters results in multiple transcript variants encoding different isoforms that vary in their functional properties. These isoforms function during skin development and maintenance, adult stem/progenitor cell regulation, heart development and premature aging. Some isoforms have been found to protect the germline by eliminating oocytes or testicular germ cells that have suffered DNA damage. Mutations in this gene are associated with ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3); split-hand/foot malformation 4 (SHFM4); ankyloblepharon-ectodermal defects-cleft lip/palate; ADULT syndrome (acro-dermato-ungual-lacrimal-tooth); limb-mammary syndrome; Rap-Hodgkin syndrome (RHS); and orofacial cleft 8. [provided by RefSeq, Aug 2016]
TP63 Gene-Disease associations (from GenCC):
  • ADULT syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • ankyloblepharon-ectodermal defects-cleft lip/palate syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • limb-mammary syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • Rapp-Hodgkin syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • premature ovarian failure 21
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • split hand-foot malformation 4
    Inheritance: AD Classification: MODERATE Submitted by: Illumina
  • EEC syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • split hand-foot malformation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.121 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TP63NM_003722.5 linkc.325-21570G>A intron_variant Intron 3 of 13 ENST00000264731.8 NP_003713.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TP63ENST00000264731.8 linkc.325-21570G>A intron_variant Intron 3 of 13 1 NM_003722.5 ENSP00000264731.3

Frequencies

GnomAD3 genomes
AF:
0.0875
AC:
13288
AN:
151842
Hom.:
650
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.123
Gnomad AMI
AF:
0.127
Gnomad AMR
AF:
0.107
Gnomad ASJ
AF:
0.0635
Gnomad EAS
AF:
0.0234
Gnomad SAS
AF:
0.0286
Gnomad FIN
AF:
0.0666
Gnomad MID
AF:
0.0605
Gnomad NFE
AF:
0.0746
Gnomad OTH
AF:
0.0816
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0876
AC:
13309
AN:
151960
Hom.:
652
Cov.:
32
AF XY:
0.0853
AC XY:
6338
AN XY:
74262
show subpopulations
African (AFR)
AF:
0.123
AC:
5118
AN:
41450
American (AMR)
AF:
0.107
AC:
1637
AN:
15244
Ashkenazi Jewish (ASJ)
AF:
0.0635
AC:
220
AN:
3466
East Asian (EAS)
AF:
0.0234
AC:
121
AN:
5166
South Asian (SAS)
AF:
0.0286
AC:
138
AN:
4818
European-Finnish (FIN)
AF:
0.0666
AC:
705
AN:
10586
Middle Eastern (MID)
AF:
0.0651
AC:
19
AN:
292
European-Non Finnish (NFE)
AF:
0.0746
AC:
5064
AN:
67922
Other (OTH)
AF:
0.0812
AC:
171
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
599
1198
1796
2395
2994
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
148
296
444
592
740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0796
Hom.:
1532
Bravo
AF:
0.0939
Asia WGS
AF:
0.0450
AC:
157
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.41
DANN
Benign
0.72
PhyloP100
-0.60
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13321831; hg19: chr3-189504491; API